Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 504261 - 504280 out of 558245 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Sweden | (N05AX13) paliperidone (adm: P, note: depot expr. as paliperidone) | Paliperidon Bijon | 3, 100 mg , Förfylld spruta, 3 st | Retail price without vat |
$0-0 |
$0-0 |
n/a | UABBIJONmedica |
| Sweden | (N05AX13) paliperidone (adm: P, note: depot expr. as paliperidone) | Paliperidon Teva | 1, 50 mg , Förfylld spruta, 1 st | Retail price without vat |
$0-0 |
$0-0 |
n/a | TevaSwedenAB |
| Sweden | (N05AX13) paliperidone (adm: P, note: depot expr. as paliperidone) | Palmeux | 1, 75 mg , Förfylld spruta, 1 st | Retail price without vat |
$0-0 |
$0-0 |
n/a | 2care4ApS |
| Sweden | (N05AX13) paliperidone (adm: P, note: depot expr. as paliperidone) | Palmeux | 1, 100 mg , Förfylld spruta, 1 st | Retail price without vat |
$0-0 |
$0-0 |
n/a | 2care4ApS |
| Sweden | (N05AX13) paliperidone (adm: P, note: depot expr. as paliperidone) | Palmeux | 1, 150 mg , Förfylld spruta, 1 st | Retail price without vat |
$0-0 |
$0-0 |
n/a | 2care4ApS |
| Sweden | (N06DA03) rivastigmine (adm: TD, delivered dose) | Exelon | 30, 13,3 mg/24 timmar , Påse, 30 x 1 plåster (papper/PET/PE/alu/PA) | Retail price without vat |
$0-0 |
$0-0 |
Dementia;Alzheimer Disease;Parkinson Disease | NovartisSverigeAB |
| Sweden | (N06DA03) rivastigmine (adm: TD, delivered dose) | Exelon | 90, 13,3 mg/24 timmar , Påse, 90 (3 x 30) plåster (papper/PET/PE/alu/PA) | Retail price without vat |
$0-0 |
$0-0 |
Dementia;Alzheimer Disease;Parkinson Disease | NovartisSverigeAB |
| Sweden | (N07BC01) buprenorphine (adm: P) | Buvidal | 1, 128 mg , Förfylld spruta, 1 st | Retail price without vat |
$0-0 |
$0-0 |
Opioid-Related Disorders | CamurusAB |
| Sweden | (N07BC01) buprenorphine (adm: P) | Buvidal | 1, 16 mg , Förfylld spruta, 1 st | Retail price without vat |
$0-0 |
$0-0 |
Opioid-Related Disorders | CamurusAB |
| Sweden | (N07BC01) buprenorphine (adm: P) | Buvidal | 1, 160 mg , Förfylld spruta, 1 st | Retail price without vat |
$0-0 |
$0-0 |
Opioid-Related Disorders | CamurusAB |
| Sweden | (N07BC01) buprenorphine (adm: P) | Buvidal | 1, 24 mg , Förfylld spruta, 1 st | Retail price without vat |
$0-0 |
$0-0 |
Opioid-Related Disorders | CamurusAB |
| Sweden | (N07BC01) buprenorphine (adm: P) | Buvidal | 1, 32 mg , Förfylld spruta, 1 st | Retail price without vat |
$0-0 |
$0-0 |
Opioid-Related Disorders | CamurusAB |
| Sweden | (N07BC01) buprenorphine (adm: P) | Buvidal | 1, 64 mg , Förfylld spruta, 1 st | Retail price without vat |
$0-0 |
$0-0 |
Opioid-Related Disorders | CamurusAB |
| Sweden | (N07BC01) buprenorphine (adm: P) | Buvidal | 1, 8 mg , Förfylld spruta, 1 st | Retail price without vat |
$0-0 |
$0-0 |
Opioid-Related Disorders | CamurusAB |
| Sweden | (N07BC01) buprenorphine (adm: P) | Buvidal | 1, 96 mg , Förfylld spruta, 1 st | Retail price without vat |
$0-0 |
$0-0 |
Opioid-Related Disorders | CamurusAB |
| Sweden | (R03DX10) benralizumab (adm: P) | Fasenra | 1, 30 mg , Förfylld spruta, 1 st, automatiskt nålskydd | Retail price without vat |
$0-0 |
$0-0 |
Asthma | AstraZenecaAB |
| Sweden | (S01EE01) latanoprost | Monoprost | 30, 50 mikrogram/ml , Endosbehållare, 30 st (3 x 10 st) | Retail price without vat |
$0-0 |
$0-0 |
n/a | EbbMedicalAB |
| Sweden | (S01EE05) tafluprost | Taflotan | 90, 15 mikrogram/ml , Endosbehållare, 90 x 0,3 ml | Retail price without vat |
$0-0 |
$0-0 |
n/a | SantenOY |
| Sweden | (S01EE05) tafluprost | Taflotan | 30, 15 mikrogram/ml , Endosbehållare, 30 x 0,3 ml | Retail price without vat |
$0-0 |
$0-0 |
n/a | SantenOY |
| Sweden | (S01LA04) ranibizumab | Lucentis® | 1, 10 mg/ml , Förfylld spruta i blister, 1 dos | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Myopia, Degenerative;Choroidal Neovascularization | NovartisSverigeAB |
Pages
